Cabaletta Bio Inc (CABA)

NASDAQ
3.430
+0.060(+1.78%)
After Hours
3.020
-0.410(-11.953%)
- Real-time Data
  • Volume:
    114,780
  • Bid/Ask:
    3.020/3.630
  • Day's Range:
    3.180 - 3.460

CABA Overview

Prev. Close
3.37
Day's Range
3.18-3.46
Revenue
-
Open
3.29
52 wk Range
3.05-14.95
EPS
-1.75
Volume
114,780
Market Cap
97.18M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
607,363
P/E Ratio
-
Beta
-
1-Year Change
-73.7%
Shares Outstanding
28,331,638
Next Earnings Date
Apr 04, 2022
What is your sentiment on Cabaletta Bio Inc?
or
Market is currently closed. Voting is open during market hours.

Cabaletta Bio Inc Company Profile

Employees
47

Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce disease-causing autoantibodies or pathogenic B cells. The company’s lead product candidate is DSG3-CAART, which is in Phase I clinical trial for the treatment of mucosal pemphigus vulgaris, an autoimmune blistering skin disease, and Hemophilia A with Factor VIII alloantibodies. Its product candidate pipeline also includes MuSK-CAART, a preclinical stage product to treat a subset of patients with myasthenia gravis; FVIII-CAART, a discovery stage product to treat a subset of patients with Hemophilia A; and DSG3/1-CAART, a discovery stage product for the treatment of mucocutaneous pemphigus vulgaris. Cabaletta Bio, Inc. has a collaboration with the University of Pennsylvania; and research agreement with The Regents of the University of California. The company was formerly known as Tycho Therapeutics, Inc. and changed its name to Cabaletta Bio, Inc. in August 2018. Cabaletta Bio, Inc. was incorporated in 2017 and is headquartered in Philadelphia, Pennsylvania.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyNeutralStrong SellStrong Sell
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong SellSell
SummaryStrong BuyStrong BuyBuyStrong SellStrong Sell
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.